# Role of Magnesium Supplementation in the Treatment of Depression

> **NCT02466087** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Vermont** · enrollment: 126 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Mg Cl

## Key facts

- **NCT ID:** NCT02466087
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-12
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2019-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02466087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02466087, "Role of Magnesium Supplementation in the Treatment of Depression". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT02466087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*